These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11824960)

  • 1. Leflunomide induced fevers, thrombocytosis, and leukocytosis in a patient with relapsing polychondritis.
    Koenig AS; Abruzzo JL
    J Rheumatol; 2002 Jan; 29(1):192-4. PubMed ID: 11824960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leflunomide for relapsing polychondritis: successful longterm treatment.
    Handler RP
    J Rheumatol; 2006 Sep; 33(9):1916; author reply 1916-7. PubMed ID: 16960961
    [No Abstract]   [Full Text] [Related]  

  • 3. Maintenance of remission with leflunomide in Wegener's granulomatosis.
    Metzler C; Fink C; Lamprecht P; Gross WL; Reinhold-Keller E
    Rheumatology (Oxford); 2004 Mar; 43(3):315-20. PubMed ID: 14963200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leflunomide induced acute interstitial pneumonia.
    Takeishi M; Akiyama Y; Akiba H; Adachi D; Hirano M; Mimura T
    J Rheumatol; 2005 Jun; 32(6):1160-3. PubMed ID: 15940779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of leflunomide-induced acute pneumonitis with cholestyramine wash-out therapy.
    Wong SP; Chu CM; Kan CH; Tsui HS; Ng WL
    J Clin Rheumatol; 2009 Dec; 15(8):389-92. PubMed ID: 19955995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of leflunomide 10 mg versus 20 mg once daily in patients with active rheumatoid arthritis: multinational double-blind, randomized trial.
    Poór G; Strand V;
    Rheumatology (Oxford); 2004 Jun; 43(6):744-9. PubMed ID: 15026583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of a leg ulcer occurring in a rheumatoid arthritis patient under leflunomide therapy.
    Knab J; Goos M; Dissemond J
    J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):243-6. PubMed ID: 15752303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leflunomide-associated pancytopenia with or without methotrexate.
    Chan J; Sanders DC; Du L; Pillans PI
    Ann Pharmacother; 2004; 38(7-8):1206-11. PubMed ID: 15187208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward a definition and method of assessment of treatment failure and treatment effectiveness: the case of leflunomide versus methotrexate.
    Wolfe F; Michaud K; Stephenson B; Doyle J
    J Rheumatol; 2003 Aug; 30(8):1725-32. PubMed ID: 12913927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial.
    Bao C; Chen S; Gu Y; Lao Z; Ni L; Yu Q; Xu J; Li X; Liu J; Sun L; He P; Ma J; Xu S; Ding C
    Chin Med J (Engl); 2003 Aug; 116(8):1228-34. PubMed ID: 12935395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When a DMARD fails, should patients switch to sulfasalazine or add sulfasalazine to continuing leflunomide?
    Dougados M; Emery P; Lemmel EM; Zerbini CA; Brin S; van Riel P
    Ann Rheum Dis; 2005 Jan; 64(1):44-51. PubMed ID: 15271770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leflunomide: a manageable safety profile.
    van Riel PL; Smolen JS; Emery P; Kalden JR; Dougados M; Strand CV; Breedveld FC
    J Rheumatol Suppl; 2004 Jun; 71():21-4. PubMed ID: 15170904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leflunomide as adjuvant treatment of dermatomyositis.
    Boswell JS; Costner MI
    J Am Acad Dermatol; 2008 Mar; 58(3):403-6. PubMed ID: 18194823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leflunomide-induced toxic epidermal necrolysis in a patient with rheumatoid arthritis.
    Hassikou H; El Haouri M; Tabache F; Baaj M; Safi S; Hadri L
    Joint Bone Spine; 2008 Oct; 75(5):597-9. PubMed ID: 18805724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe cutaneous adverse drug reaction to leflunomide: a report of two cases.
    Jian X; Guo G; Ruan Y; Lin D; Li X
    Cutan Ocul Toxicol; 2008; 27(1):5-9. PubMed ID: 18330828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis.
    Lee SS; Park YW; Park JJ; Kang YM; Nam EJ; Kim SI; Lee JH; Yoo WH; Lee SI
    Scand J Rheumatol; 2009; 38(1):11-4. PubMed ID: 19191187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of infliximab used in combination with leflunomide or azathioprine in daily clinical practice.
    Perdriger A; Mariette X; Kuntz JL; Brocq O; Kara-Terki R; Loet XL; Cantagrel A; Pavy S; Deslandre CJ; Debiais F; Combe B;
    J Rheumatol; 2006 May; 33(5):865-9. PubMed ID: 16652418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syringotropic hypersensitivity reaction associated with infliximab and leflunomide combination therapy in a child with psoriatic arthritis.
    Vesel T; Luzar B; Calonje E; Avcin T
    J Cutan Pathol; 2009 Sep; 36(9):991-4. PubMed ID: 19017039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leflunomide-associated infections in rheumatoid arthritis.
    Jenks KA; Stamp LK; O'Donnell JL; Savage RL; Chapman PT
    J Rheumatol; 2007 Nov; 34(11):2201-3. PubMed ID: 17937473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leflunomide and azathioprine combination in refractory adult-onset Still's disease.
    Cefle A
    Ann Pharmacother; 2005 Apr; 39(4):764-7. PubMed ID: 15741418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.